Suvretta Capital Management
$4.8B 13F equity value
110 Holdings
Quarter ended June 30, 2026
The latest 13F on file for Suvretta Capital Management covers the quarter ended June 30, 2026. Institutional managers report holdings quarterly to the SEC, so each filing is a snapshot of positions held on that date.
Top Holdings
| Ticker | Company | Shares | Value | Weight |
|---|---|---|---|---|
| MANE | VERADERMICS INC | 4,168,970 | $513M | 10.8% |
| ARQT | ARCUTIS BIOTHERAPEUTICS INC | 12,437,000 | $326M | 6.9% |
| LEGN | LEGEND BIOTECH CORP | 7,070,000 | $204M | 4.3% |
| PVLA | PALVELLA THERAPEUTICS INC NE | 1,135,406 | $174M | 3.6% |
| AVBP | ARRIVENT BIOPHARMA INC | 4,515,531 | $157M | 3.3% |
| BNTC | BENITEC BIOPHARMA INC | 11,548,351 | $155M | 3.2% |
| BHVN | BIOHAVEN LTD | 10,286,937 | $153M | 3.2% |
| AMD | ADVANCED MICRO DEVICES INC | 257,240 | $149M | 3.1% |
| RCUS | ARCUS BIOSCIENCES INC | 4,776,423 | $147M | 3.1% |
| TSM | TAIWAN SEMICONDUCTOR MANUFAC | 304,627 | $145M | 3.1% |
Track Suvretta Capital Management's 13F portfolio: $4.8B in reported holdings, 110 positions. Top holdings and quarterly changes on SentiSense.
This page is powered by the SentiSense API: GET /api/v1/institutional/institution/{slugOrCik}